APSTRAKT
port (the role of glucokinase) and induces numerous lesions in the beta-cell DNA chain (3) (4) (5) . It can selectively bind to glucose-transport protein 2 (GLUT2), which is predominantly expressed on the membranes of pancreatic beta-cells (3) .
Toxicity of the streptozotocin on beta-cells is complex and includes genetic and non-genetic mechanisms (6) . Nitric oxide (NO) and other free radicals influenced by streptozotocin result in spontaneous lesions of the DNA chain (7) . Damaged DNA chains activate poly-(ADP-ribose) polymerase (PARP) as a reparatory mechanism, which in case of over-activation may have proapoptotic effects (8) . PARP knockout mice were shown to be resistant for streptozotocin-induced diabetes (8) .
In addition, the toxicity of streptozotocin is associated with a drastic decrease of insulin reserves within beta cells, resulting from the fast catabolism of nicotinamide-adenine-dinucleotide+ (NAD+), a substrate for PARP activation (9) . Decrease of NAD+ and ATP+ provokes significant depletion of insulin secretion as well as other basic processes inside the cell. While excessive activation of PARP represents a proapoptotic stimulus, the reduction of necessary cell energy results in cellular necrotic death.
A single high dose of streptozotocin provokes diabetes in rodents, possibly as a result of the direct toxic effect. Multiple low-dose streptozotocin-induced diabetes (when streptozotocin is administered in lower doses (40 mg/kg) during five consecutive days) is an experimental model of type 1 diabetes and immune-mediated insulitis and is widely used for studying the immunological background of this disease (10) .
Partial pancreatectomy
The partially pancreatectomised rat was one of the first experimental models of diabetes (11) . The surgical removal of 90% of the pancreatic tissue resulted in a slow development of hyperglycemia over the course of 12 weeks to 20 months (12) . The period of post-surgical euglycemia is followed by the development of chronic hyperglycemia as a consequence of a further failure of the remaining beta cells.
The first stage of disease refers to glucose intolerance followed by a compensatory hyper-function of beta-cells, the exhaustion of the remaining beta cells and their further breakdown 14 weeks after surgery (12) . Altered beta cell gene expression is associated with a decreased production of islet amylin polypeptide (IAPP), transcription factors, ionic canals and pumps, including GLUT2, glucokinase, mitochondrial glycerophosphate dehydrogenase (mGPD) and pyruvate carboxylase (13) . A reduction of insulin secretion follows even in conditions of high concentrations of glucose and even after application of insulin secretagogues (14) .
Histopathological findings demonstrate hypertrophy and fibrosis of pancreatic islets related to the level of hyperglycemia (13) . Insulitis, demonstrated as the infiltration of inflammatory cells, may be depressed, thus slowing down the process of cell degeneration (15) .
INTRODUCTION
Since 1880, when von Mering and Minkowski removed the pancreas from a dog displaying symptoms of diabetes mellitus (1), many experiments have been conducted on mice, rats, rabbits, and dogs, which were all used as experimental models for this disease.
The rodents (mice and rats) are most frequently used in laboratory research of type 1 and type 2 diabetes because they are biologically and genetically similar to people, their reproductive potential is high, their life span is short, and they are cheap and easy to handle (1) . The main drawback of these models is that sometimes they are unable to successfully simulate pathological processes occurring in humans; in those situations, the use of cats, dogs, pigs or primates is justifiable.
Models of experimental diabetes are: 1. induced (experimental) 2. spontaneous (genetically induced) or 3. transgenic and knock-out models (resulting from genetic engineering).
Hyperglycemia is induced by: 1. surgical method (partial or total pancreatectomy) 2. non-surgical method (using a diabetogenic toxin in experimental animals) ( Table 1 ) (2).
MATERIALS AND METHODS
We searched the electronic databases Medline, Highwire, and Hinari. Selected papers, both original and review, have been summarized and cited with regard to their scientific relevance for this research field. The disorder is autoimmune, and insulitis is characterized by the infiltration of T lymphocytes, B lymphocytes, macrophages and NK cells (23) . Typical for this species is extreme lymphopenia associated with a decreased number of T lymphocytes with an elevated expression of ADP-ribosyltransferase 2 (ART2); this has not been registered in the human population (24) . A transfusion of histocompatible T ART2+ lymphocytes prevents spontaneous hyperglycemia in this model (24) . Recent studies show that BB rat diabetic syndrome is a complex, polygenic disease that may share additional susceptibility genes aside from MHC class II with human type 1 diabetes (25) . The expression of two main susceptibility genes is responsible for the development of diabetes in the BB rat: MHC (RT1) class II u haplotype (Iddm1) and the Gimap5 (GTPase immunity associated protein family member 5) gene, a key genetic factor for lymphopenia in spontaneous BB rat diabetes (Iddm2) (25) .
EXPERIMENTAL MODELS OF TYPE 1 DIABETES MELLITUS

A) Induced models
EXPERIMENTAL MODELS OF TYPE 2 DIABETES
A) Induced models C57BL/6J mouse fed a high-fat diet This model was originally introduced by Surwit et al. in 1988 as a robust model of impaired glucose tolerance (IGT) and early type 2 diabetes (26). C57BL/6J mice fed a high-fat diet (58% energy by fat, a "Western diet") developed hyperglycemia, hyperinsulinemia, hyperlipidemia and increased adiposity (27) . High-fat diet results in insulin resistance with compensatory hyperinsulinemia. After one week on the diet, baseline plasma glucose and insulin are significantly elevated and intravenous glucose tolerance test (IVGTT) shows reduced glucose elimination and impaired insulin secretion (28) . The model thus shows two important pathophysiological characteristics for impaired glucose tolerance (IGT) and type 2 diabetes: insulin resistance and islet dysfunction.
In this model, the weight gain is due primarily to an increase in mesenteric adiposity. In high-fat diet-fed mice, energy intake is higher and metabolic efficiency index is lower compared to normal diet-fed mice (28) . Despite obesity, plasma leptin levels are significantly lower than in the control group in the absence of hyperphagia (29) . Increased serum lipid levels develop concomitantly with the development of hyperglycemia, thus deteriorating insulin resistance and producing lipid deposits in non-adipose cells, including beta cells and skeletal muscle cells (30) . Microscopically, a high-fat diet induces hypertrophy of pancreatic islets (31) .
This model is suitable for examining novel therapeutic interventions. The dipeptidyl peptidase-IV (DPP-IV) inhibitor is efficient in improving glucose tolerance and insulin secretion in the high-fat diet-fed mouse model (28) .
Partial pancreatectomy as a surgical method of inducing diabetes was described above.
B) Spontaneous models
The most frequently used spontaneous models of type 1 diabetes are the non-obese diabetic (NOD) mouse and the bio-breeding (BB) rat. These two strains are the result of laboratory inbreeding (keen cross-breeding) of a large number of generations; they develop the disease spontaneously, similar to type 1 human diabetes.
NOD mouse
The NOD mouse is an inbred, homozygous strain discovered in 1974 in Shionogi Research Laboratories in Osaka, Japan. It was a result of keen cross-breeding from normoglycemic strains used for cataract research (Jcl-ICR mouse) and bred in sterile conditions, free from species-specific pathogens (16) . The NOD mouse developed insulitis detectable by electronic microscopy after 2 weeks, and within 4-5 weeks it becomes visible under standard microscopy (17) . The infiltration is mainly characterized by the presence of a large number of CD 4+ T lymphocytes, while CD 8+ T and B lymphocytes, as well as NK cells are not so numerous (18) . Insulitis is progressive and accompanied by the destruction of beta cells and a decrease of insulin levels in serum. In contrast to the disease in the human population, these strains have mild ketoacidosis and can survive for weeks without insulin substitution (1). Incidence of this disease differs between genders (90% among females and 60% among males) (1) .
Similar to the human population, the main autoantigenes in pathogenesis of this disease, recognized by secreted antibodies, are insulin, glutamic acid decarboxylase (GAD), and tyrosine phosphatase (ICA512, known as IA-2) (19) .
The genetic background of diabetes in this model highlights the role of a major histocompatibile complex (MHC) class II gene that codes for molecule I-A g7 (20) (21) . The expression of MHC molecule class I refers to proteins K d and D b (22) . An alteration of INS gene expression, controlling the expression of insulin in the thymus and the deletion of T reactive lymphocytes in the case of central tolerance, is related to an initiation of the autoimmune process (22) . A similar situation is observed with the cytotoxic T lymphocyte antigen 4 (CTLA-4) gene, which codes for a negative signal molecule for CD8+ T cells and controls the activation and expansion of T lymphocytes (22) . The protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene, associated with autoimmune diabetes, codes for tyrosine phosphatase (LYP or PEP), a negative regulator of T cells (22) . Variations of genes coding for IL2 and CD25 FoxP3 + that a key role in maintaining immune homeostasis are common for both human and NOD mice (22) .
BB rat
The BB rat was discovered in 1974 within the commercial campaign of the Company Bio Breeding Laboratories, Ottawa. It develops diabetes spontaneously (decrease of body weight, polyuria, polydipsia, hyperglycemia and insulopenia) during puberty-approximately the 12 th week of life (1). Similar to the human population, the BB rat develops serious/fatal ketoacidosis unless insulin substitution is administered. (1)
B Spontaneous models
Goto Kakizaki Rat
The Goto Kakizaki (GK) rat is skinny, diabetic rat developed in Japan in 1975 from Wistar species (6) . Both insulin resistance and impaired insulin secretion are present in this model (32) . GK rats have a decreased numbers of beta cells at birth, which is probably the consequence of their apoptosis during embryonic development (16-18 day). However, GK rats are still normoglycemic and without marked changes in islet morphology at birth (33) . The characteristics of diabetes type 2 in this model are mild hyperglycemia (9 mmol/l) in the fourth week and the increase of basal insulin secretion and insulin resistance followed by a decrease in glucose tolerance (34) . GK rats are resistant to food intake restrictions (35) .
Starting from the 8 th week, insulin islets show signs of fibrosis with a marked elevation of hyperglycemia (36) . In addition, the expression of CD38 and GLUT2 proteins is reduced in GK islets (37) (38) . Microscopically, numerous macrophages (major histocompatibility complex class II + and CD68 + ) and granulocytes were found in and around pancreatic islets (39) . Elevated islet IL-1β activity in GK rat promotes cytokine and chemokine expression, leading to the recruitment of innate immune cells (40) . Treatment of GK rats with IL-1 receptor antagonists decreases hyperglycemia, reduces the proinsulin/ insulin ratio and improves insulin sensitivity (40) .
The most important factor for the disorder of insulin secretion is the dysfunction of glucose metabolism connected with a deficiency of enzymes that control oxidative glycolysis (6) . The GK rat develops some features that can be compared with the complications of diabetes seen in humans (1).
Zucker Fatty and Zucker Fatty Diabetic Rat
The Zucker Fatty (ZF) rat has a defect of a gene that codes for leptin receptors (fa/fa), resulting in the development of obesity and hypertension with associated renal and cardiovascular disease (6) . The Zucker Fatty Diabetic Rat (ZDF) has the identical genetic mutation and, additionally, a mutation which leads to the spontaneous development of hyperglycemia in males during the 7 th -10 th week (41) . The females become hyperglycemic only after high-fat diet, and it is supposed that this additional mutation is expressed in beta cells (42) . Leptin suppresses insulin secretion and controls food intake. The fa/fa mutation of the leptin receptor results in insulin resistance with severe glucose intolerance (6) . ZF and ZDF rats are hyperphagic due to the reduction in leptin signalling that results in obesity (6) . These animals, in adulthood, become extremely dislipemic with increased concentration of free fatty acids, cholesterol, and triglycerides in plasma with a consequent development of diabetes mellitus complications (cardiovascular, renal, and peripheral neuropathy) (6, (43) (44) .
Pancreatic islets in adults show increased beta cell activity, with marked characteristics of a prediabetic state (6) . After the onset of diabetes, pancreatic islets become irregular as a result of hyperplasia, hypertrophy and infiltration of inflammatory cells (45) . An almost complete absence of beta cells was detected by the 14 th week of age (45) . Reduced expression of mGDP and pyruvate carboxylase activity was noticed in this model (46) .
Otsuka Long Evans Tokushima Fatty Rat
The Otsuka Long Evans Tokushima Fatty Rat (OLETF) is derived by inbreeding from the glucose-intolerant LongEvans colony of rats (47) . These animals develop hyperglycemia slowly, by 40 weeks of age, with greater incidence in males than in females (1) . Adult animals are mildly obese and hyperglycemic, with increased appetite and renal glomerulosclerosis. These changes are the result of a deletion of the gene for cholecystokinin 1 receptors. Diet and exercise prevent type 2 diabetes in this model (48) .
Histopathologic changes inside the islets during the 8 th -10 th week show an infiltration of inflammatory cells followed by tissue damage. Beta cell hyperplasia and proliferation occur between the 20 th and 40 th weeks, while atrophy and fibrosis of the islets start after the 40 th week (47) . From the 72 nd week, inflammatory cytokines (tumour necrosis factor-(TNF-), interleukin-1β (IL-1β) and interleukin-6 (IL-6)) are detectable by immunohistochemical method (49) .
Psammomys obesus
The Psammomys obesus is rat from North America and the Middle East. It usually feeds on a low-calorie diet and demonstrates the strong effect of a high-calorie diet by developing hyperglycemia within 4-7 days (6).
Pathogenesis of the disorders goes through four typical stages: normoglycemia and normoinsulinemia, normoglycemia with hyperinsulinemia (indicating insulin resistance), hyperglycemia with hyperinsulinemia, and hyperglycemia with hypoinsulinemia (50) . The last stage is characterized by marked apoptosis and a reduction of beta cell mass (51) . Returning to a low-calorie diet results in the recovery of beta cells, indicating that the irreversible loss of beta cell mass is a late event (52) .
TRANSGENIC AND KNOCKOUT MODELS OF DIABETES MELLITUS
In experimental diabetes, numerous transgenic and knockout models are being used. These models have been created by genetic manipulations using either transgene insertion and/or targeted gene-deletion approaches.
Still, these techniques have some limitations. Some homozygotes may die in the womb, which makes studies in adults impossible. Several genes could function differently during embryogenesis and in adulthood. Finally, some models' gene expression is altered in soft tissues, and therefore it is impossible to analyze their function in the desired tissue. Tissue-specific knockout models for diabetes, in which the gene being studied is only knocked out in specific tissues, were created to address this issue.
The first knockout models of insulin resistance aimed at the disruption of major molecules in insulin receptor (IR) signaling. Heterozygous IR knockout mice show 50% of IR expression, which is sufficient for the maintenance of physiological blood glucose contentrations (53) . In contrast, homozygous IR-deficient mice rapidly develop diabetic ketoacidosis and die within 3-7 days after birth, showing the central role of IR in glucose metabolism (54) . Aside from IR knockouts, various molecules of the signal transduction pathway initiated by IR have been disrupted, such as insulin receptor substrates (IRS-1, IRS-2, IRS-3) (55-58). Insulin resistance and insulin secretory defects have also been presented by a generation of mice deficient in beta cell glucokinase (GK). The heterozygous beta cell GK knockout mouse is characterised by decreased insulin secretion in response to glucose (59) . The homozygous knockout mouse model with a disrupted gene for the glucose transporter 4 (GLUT4), which mediates glucose transport in muscle and adipose tissue in response to insulin, is characterised by mild changes in glucose hemostasis, growth retardation, reduction of fat and cardiac hypertrophy (60) . The important physiological role of peroxisome proliferator-activator receptors (PPARα and PPARγ) was deduced from findings identifying the PPARs as primary targets of tiasolidinedione insulin sensitizers and fibrates that have been used in the successful treatment of diabetes and dyslipidemia. Diverse knockout models have been created to study the function of single PPARs isoforms (61) (62) (63) . Similar to other mouse models, a transgenic human islet amyloid polypeptide-expressing rat has been recently developed (64) . This model shows pancreatic amyloidosis, insulin resistance, and reduced β-cell mass with resulting hyperglycemia (64) . Some of the transgenic/knockout and tissue-specific knockout models are presented in Table 2 . 
